A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen
Condition: Asthma Interventions: Drug: AZD8154 nebulizer suspension, 20 mg/mL; Drug: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials